Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

The Lancet Haematology

Fecha de publicación: 12 june 2018

DOI: https://doi.org/10.1016/S2352-3026(18)30051-6

Autores: Gita Thanarajasingam, MD., Lori M Minasian, MD., Prof Frederic Baron, MD., Prof Franco Cavalli, MD., R Angelo De Claro, MD., Amylou C Dueck, PhD.

Background: Tremendous progress in treatment and outcomes has been achieved across the whole range of haematological malignancies in the past two decades. Although cure rates for aggressive malignancies have increased, nowhere has progress been more impactful than in the management of typically incurable forms of haematological cancer. 

Seguir leyendo